| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |